Literature DB >> 21491928

Exploiting the facile release of trifluoroacetate for the α-methylenation of the sterically hindered carbonyl groups on (+)-sclareolide and (-)-eburnamonine.

Mark V Riofski1, Jinu P John, Mary M Zheng, Julia Kirshner, David A Colby.   

Abstract

An efficient method for the α-methylenation of carbonyl groups is reported, and this transformation is accomplished by a facile elimination of trifluoroacetate during the formation of the olefin. This method represents an improvement beyond existing protocol in cases of steric hindrance, and we have demonstrated the utility of the process across a series of ketones, lactams, and lactones. Additionally, we have applied this method to produce semisynthetic derivatives of the natural products (+)-sclareolide and (-)-eburnamonine, in which the carbonyl group is proximal to bulky functional groups. Mechanistic insight is also provided from a time course of (19)F NMR. Biological evaluation of the natural-product-derived enones led to the identification of a derivative of (-)-eburnamonine with significant cytotoxicity (LC(50) = 14.12 μM) in drug-resistant MDA-MB-231 breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491928     DOI: 10.1021/jo102114f

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  9 in total

1.  Deacylative allylation: allylic alkylation via retro-Claisen activation.

Authors:  Alexander J Grenning; Jon A Tunge
Journal:  J Am Chem Soc       Date:  2011-08-24       Impact factor: 15.419

2.  Halocarbocyclization entry into the oxabicyclo[4.3.1]decyl exomethylene-δ-lactone cores of linearifolin and zaluzanin A: exploiting combinatorial catalysis.

Authors:  Sandeep K Ginotra; Jacob A Friest; David B Berkowitz
Journal:  Org Lett       Date:  2012-02-08       Impact factor: 6.005

3.  Synthesis of 15-methylene-eburnamonine from (+)-vincamine, evaluation of anticancer activity, and investigation of mechanism of action by quantitative NMR.

Authors:  James R Woods; Mark V Riofski; Mary M Zheng; Melissa A O'Banion; Huaping Mo; Julia Kirshner; David A Colby
Journal:  Bioorg Med Chem Lett       Date:  2013-09-06       Impact factor: 2.823

4.  Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation.

Authors:  Xingui Liu; Yingying Wang; Xuan Zhang; Zhengya Gao; Suping Zhang; Peizhong Shi; Xin Zhang; Lin Song; Howard Hendrickson; Daohong Zhou; Guangrong Zheng
Journal:  Bioorg Med Chem       Date:  2018-06-18       Impact factor: 3.641

5.  Synthesis of α-halo-α,α-difluoromethyl ketones by a trifluoroacetate release/halogenation protocol.

Authors:  Jinu P John; David A Colby
Journal:  J Org Chem       Date:  2011-10-13       Impact factor: 4.354

6.  15-Methylene-Eburnamonine Kills Leukemic Stem Cells and Reduces Engraftment in a Humanized Bone Marrow Xenograft Mouse Model of Leukemia.

Authors:  Dilini C Gunasekara; Mary M Zheng; Tara Mojtahed; James R Woods; Tamer E Fandy; Mark V Riofski; Carlotta A Glackin; Hazem E Hassan; Julia Kirshner; David A Colby
Journal:  ChemMedChem       Date:  2016-09-28       Impact factor: 3.466

7.  Optimized Synthesis of a Pentafluoro-gem-diol and Conversion to a CF2Br-Glucopyranose through Trifluoroacetate-Release and Halogenation.

Authors:  Robert A Hazlitt; Jinu P John; Que-Lynn Tran; David A Colby
Journal:  Tetrahedron Lett       Date:  2016-03-19       Impact factor: 2.415

8.  Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening.

Authors:  Hasan Tükenmez; Isabel Edström; Ramesh Ummanni; Stina Berglund Fick; Charlotta Sundin; Mikael Elofsson; Christer Larsson
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

9.  An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity.

Authors:  Md Imran Hossain; Ajit G Thomas; Fakhri Mahdi; Amna T Adam; Nicholas S Akins; Morgan M Woodard; Jason J Paris; Barbara S Slusher; Hoang V Le
Journal:  RSC Adv       Date:  2021-02-10       Impact factor: 3.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.